| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
1e-14 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
8e-12 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-11 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-10 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-09 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-09 |
| mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-08 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-08 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-08 |
| mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
8e-08 |